CVRx, Inc. (CVRX)

Market Cap	205.29M
Revenue (ttm)	54.65M
Net Income (ttm)	-52.25M
Shares Out	26.15M
EPS (ttm)	-2.10
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	115,924
Open	7.94
Previous Close	7.88
Day's Range	7.61 - 8.04
52-Week Range	4.30 - 18.55
Beta	1.23
Analysts	Buy
Price Target	14.00 (+78.34%)
Earnings Date	Oct 28, 2025

About CVRX

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, a neuromodulation device that enhance symptoms for patients with heart failure by delivering electrical pulses to baroreceptors. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minn...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jun 30, 2021
• Employees: 206
• Stock Exchange: NASDAQ
• Ticker Symbol: CVRX
• Website: https://www.cvrx.com

Financial Performance

In 2024, CVRx, Inc.'s revenue was $51.29 million, an increase of 30.53% compared to the previous year's $39.30 million. Losses were -$59.97 million, 45.5% more than in 2023.

Analyst Summary

According to 7 analysts, the average rating for CVRX stock is "Buy." The 12-month stock price target is $14.0, which is an increase of 78.34% from the latest price.

Price Target

$14.0

(78.34% upside)

Analyst Consensus: Buy